Semaglutide helps regulate blood sugar, supports weight loss by reducing appetite, and improves heart health by lowering the risk of cardiovascular events. It also enhances metabolism and may reduce inflammation.

Semaglutide mimics the GLP-1 hormone, which regulates blood sugar, slows digestion, and reduces appetite. This helps control glucose levels, promote weight loss, and improve heart health.

Tirzepatide helps regulate blood sugar, supports significant weight loss by reducing appetite, and improves heart health. It also enhances insulin sensitivity and metabolism.

Tirzepatide acts on both GLP-1 and GIP receptors, enhancing insulin release, reducing hunger, and slowing digestion. This dual-action approach leads to better blood sugar control and greater weight loss.

Semaglutide is used for weight loss, to lower blood sugar levels in type 2 diabetes, and to reduce the risk of major cardiovascular events and chronic kidney disease in certain adult patients. 

Semaglutide works by mimicking a natural hormone called glucagon-like peptide-1 (GLP-1), which is released in the gut after eating, essentially signaling to the body that it is full; this action primarily leads to decreased appetite, slower stomach emptying, and increased insulin production, resulting in lower blood sugar levels and potential weight loss when used alongside diet and exercise. 

It typically takes about two weeks for semaglutide to start working in the body. While taking semaglutide, some people begin to see results within the first eight weeks, but most begin to see results within 12 weeks

This medicine is given as an injection under the skin of your stomach, thighs, or upper arm.

No insurance required, no hidden fees. Low monthly payments